263 related articles for article (PubMed ID: 2612330)
41. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
42. COTA (colon-ovarian tumor antigen). An immunohistochemical study.
Pant KD; Fenoglio-Preiser CM; Berry CO; Zamora PO; Ram MD; Fulks RM; Rhodes BA
Am J Clin Pathol; 1986 Jul; 86(1):1-9. PubMed ID: 3524190
[TBL] [Abstract][Full Text] [Related]
43. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
44. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
45. [Acute phase protein (alpha 1 AT) as a tumor marker in patients with ovarian cancer (OC)].
Kawai M; Iida N; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y
Gan No Rinsho; 1989 Jun; 35(7):799-803. PubMed ID: 2472494
[TBL] [Abstract][Full Text] [Related]
46. [Assessment of the activity of tumor necrosis factor in normal state and in ovarian tumors].
Koval'chuk LV; Pavliuk AS; Aksenova NIa; Iakovleva NV; Nalbandian SV; Ul'ianova TIu
Biull Eksp Biol Med; 1990 Jun; 109(6):571-3. PubMed ID: 2397296
[TBL] [Abstract][Full Text] [Related]
47. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
Tohya T; Iwamasa T; Maeyama M
Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
Aalto ML; Selkäinaho K; Collan Y
Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
[TBL] [Abstract][Full Text] [Related]
49. [Monoclonal antibodies in the radioimmunological diagnosis of malignant tumors of the gastrointestinal tract and ovaries].
Tkacheva GA; Blokhina NG; Klimenkov AA; Kozachenko VP
Vopr Onkol; 1985; 31(5):36-42. PubMed ID: 2409674
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of HLA-DR antigen in serous ovarian tumors.
Tamiolakis D; Kotini A; Venizelos J; Jivannakis T; Simopoulos C; Papadopoulos N
Clin Exp Med; 2003 Sep; 3(2):113-8. PubMed ID: 14598186
[TBL] [Abstract][Full Text] [Related]
51. Parovarian cystadenocarcinoma of low malignant potential.
White CD; Cooper WL; Williams RR; Macatol FR; DeJosef AB
W V Med J; 1991 Nov; 87(11):516-7. PubMed ID: 1819876
[TBL] [Abstract][Full Text] [Related]
52. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
Sun ZC
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
[TBL] [Abstract][Full Text] [Related]
53. Role of Ca 125 as tumor marker in ovarian carcinoma.
Krebs HB; Goplerud DR; Kilpatrick SJ; Myers MB; Hunt A
Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours.
Boerman OC; Makkink WK; Thomas CM; Hanselaar AG; Yedema CA; Kenemans P; Poels LG
Eur J Cancer; 1990 Feb; 26(2):117-27. PubMed ID: 2138906
[TBL] [Abstract][Full Text] [Related]
55. Ovarian tumor-specific antigens.
Knauf S; Urbach GI
Am J Obstet Gynecol; 1974 Aug; 119(7):966-70. PubMed ID: 4135399
[No Abstract] [Full Text] [Related]
56. [CA 125 in the diagnosis and evaluation of the efficacy of the treatment of cancer of the ovaries].
Sagan DL; Chebotareva ED; Evtushenko GV
Med Radiol (Mosk); 1989 Jun; 34(6):39-42. PubMed ID: 2739519
[TBL] [Abstract][Full Text] [Related]
57. [Cystic tumors of the pancreas].
Hurtado Andrade H; Cortés Espinosa T
Rev Gastroenterol Mex; 1997; 62(3):218-26. PubMed ID: 9480530
[TBL] [Abstract][Full Text] [Related]
58. Huge primary retroperitoneal mucinous cystadenoma of borderline malignancy mimicking an ovarian mass: case report and review.
Bifulco G; Mandato VD; Giampaolino P; Nappi C; De Cecio R; Insabato L; Tarsitano F; Mignogna C
Anticancer Res; 2008; 28(4C):2309-15. PubMed ID: 18751411
[TBL] [Abstract][Full Text] [Related]
59. Ovarian serous cystadenoma.
Tarlowska L; Sikorowa L; Piatkowski Z
Pol Med J; 1972; 11(2):368-79. PubMed ID: 5071524
[No Abstract] [Full Text] [Related]
60. [Mucinous cystadenomas and cystadenocarcinomas of the pancreas--the pancreaticoscopy as a new device for endoscopic and histological diagnosis].
Zimmer B; Brune I; Kohler B; Wegener K; Schönleben K; Riemann JF
Z Gastroenterol; 1994 Mar; 32(3):165-9. PubMed ID: 8197813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
